Strategic Acquisition TechLab is a brand under SSI Diagnostica Group, a global IVD leader with extensive manufacturing and distribution capabilities across multiple regions. This presents an opportunity to cross-sell SSI’s broad infectious disease diagnostics portfolio to TechLab’s existing customer base and leverage SSI’s global footprint for larger international deals.

Expanded Capacity With TechLab now integrated into a larger diagnostics group and reporting revenue in the mid-range, there is potential to scale manufacturing partnerships, accelerate product launches, and co-develop new diagnostic assays that align with SSI Diagnostica’s disease focus areas.

Key Partnering Recent recognition as a top new partner and the acquisition history signal a relationship-driven sales approach. Target opportunities include joint marketing, bundled offerings, and preferred supplier agreements to secure longer-term contracts with healthcare providers and distributors.

Global Reach SSI Diagnostica operates in 130+ countries with 60M+ tests manufactured annually. This provides a compelling path to introduce TechLab products into new geographies via SSI’s established channels, leveraging existing distributors and regulatory support.

Diverse Portfolio Fit SSI’s four disease focus areas align with TechLab’s medical equipment strengths. There is potential to position TechLab’s instruments and consumables alongside SSI’s infectious disease solutions, enabling end-to-end testing workflows for hospitals, laboratories, and clinics.